Researchers question safety of mist inhalers for delivering common drug for chronic lung disease
People who use a mist inhaler to deliver a drug widely prescribed in more than 55 countries to treat chronic obstructive pulmonary disease (COPD) may be 52 percent more likely to die, new Johns Hopkins-led research suggests.
Jun 15, 2011
0
0